Slingshot Insights | Bausch + Lomb Overview

BAUSCH + LOMB Overview

Upcoming Projects (BAUSCH + LOMB)

Don’t see a project related to the company you care about? Create your own!

Upcoming & Overdue Catalysts (BAUSCH + LOMB)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (BAUSCH + LOMB)

PDUFA Date of August 24th for Valeant's (VRX) Latanoprostene Bunod Ophthalmic Solution for Lowering Intraocular Pressure (IOP) in Patients with Open Angle Glaucoma or Ocular Hypertension
Tickers: VRX, COX.PA, Bausch + Lomb
Occurred on: Aug 07, 2017
Valeant's (VRX) Bausch + Lomb Resubmits New Drug Application (NDA) for Latanoprostene Bunod Ophthalmic Solution for Lowering Intraocular Pressure in Patients with Open Angle Glaucoma or Ocular Hypertension
Tickers: VRX, Bausch + Lomb
Occurred on: Feb 27, 2017

Strategic Initiatives (BAUSCH + LOMB)

Don’t see a strategic initiative related to the company you care about? Create your own!